SHARE OFFERINGS AND FEES

3 Months Ended

Sep. 30, 2025

SHARE OFFERINGS AND FEES [Abstract]

SHARE OFFERINGS AND FEES

NOTE 11 – SHARE OFFERINGS AND FEES

As discussed in Note 1, on August 26, 2024, in connection with our agreement with Maxim, the Company issued through a private placement agreement an aggregate amount of 13,300 shares of common stock to Maxim’s affiliate, approximately 1% of the Company’s outstanding stock.

As discussed in Note 1, on January 30, 2025, in connection with our agreement with OTB Capital, the Company issued through a private placement agreement an aggregate amount of 8,583.70 shares of common stock to OTB Capital, approximately $0.20 million worth of shares.

As discussed in Note 1, on February 28, 2025, in connection with the Registered Offering, the Company issued 153,403.40 shares of the Company’s common stock, $0.0001 par value per share, pre-funded warrants to purchase up to 129,226.50 shares of common stock and, in a concurrent private placement and together with the Registered Offering, warrants to purchase up to an aggregate of 423,944.85 shares of common stock, approximately $4.80 million worth of shares. In March 2025, we issued 32.18 shares of common stock at $102.50 per share to the Class A unit holders of the Operating Partnership who exercised their option to convert their Class A units to our common share at a 10:1 ratio, and 15,668.10 shares of common stock to the Series A preferred stock holders who exercised their option to convert their shares of Series A preferred stock to shares of our common stock at price per shares ranging from $11.50 to $40.20.

During the three months ended September 30, 2025, we issued 1,377.78 shares of Series A preferred stock with total gross proceeds of $31,000, 4,100.45 shares of Series B preferred stock with total gross proceeds of $102,511, and 27,520.00 shares of Series C preferred stock with total gross proceeds of $688,000 under the Second Offering Circular; and we incurred syndication costs of $165,236 in relation to common and preferred stock offerings. For the three months ended September 30, 2025, we issued 2,380.34 shares of Series A preferred stock with total gross proceeds of $53,558 under the preferred stock DRIP, 281.28 shares of Series B preferred stock with total gross proceeds of $6,328 under the preferred stock DRIP, and converted 7,051.54 shares of Series A preferred stock at $1 per share to 36,251 shares of our common stock.

During the three months ended September 30, 2024, we issued 2,000 shares of Series A preferred stock with total gross proceeds of $50,000 and 14,260 shares of Series B preferred stock with total gross proceeds of $356,499 under the Offering Circular and incurred syndication costs of $46,011 in relation to preferred stock offering. For the three months ended September 30, 2024, we issued 2,059.14 Series A preferred stock with total gross proceeds of $46,333 under the preferred stock DRIP and 84.96 Series B preferred stock with total gross proceeds of $1,912 under the preferred stock DRIP.